Annual Current Assets
$14.14 B
+$909.40 M+6.87%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual total current assets is currently $14.14 billion, with the most recent change of +$909.40 million (+6.87%) on 31 December 2023. During the last 3 years, it has risen by +$6.01 billion (+73.90%). VRTX annual current assets is now at all-time high.VRTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$9.80 B
+$862.50 M+9.65%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly total current assets is currently $9.80 billion, with the most recent change of +$862.50 million (+9.65%) on 30 September 2024. Over the past year, it has dropped by -$4.89 billion (-33.29%). VRTX quarterly current assets is now -33.29% below its all-time high of $14.70 billion, reached on 30 September 2023.VRTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | -33.3% |
| 3 y3 years | +73.9% | +10.8% |
| 5 y5 years | +268.0% | +105.2% |
VRTX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.9% | -33.3% | +10.8% |
| 5 y | 5 years | at high | +268.0% | -33.3% | +105.2% |
| alltime | all time | at high | >+9999.0% | -33.3% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.80 B(+9.6%) |
| June 2024 | - | $8.94 B(-32.7%) |
| Mar 2024 | - | $13.29 B(-6.0%) |
| Dec 2023 | $8.59 B(+74.7%) | $14.14 B(-3.8%) |
| Sept 2023 | - | $14.70 B(+5.9%) |
| June 2023 | - | $13.87 B(+7.0%) |
| Mar 2023 | - | $12.97 B(-2.0%) |
| Dec 2022 | $4.92 B(+27.0%) | $13.23 B(+7.9%) |
| Sept 2022 | - | $12.27 B(+6.7%) |
| June 2022 | - | $11.50 B(+11.0%) |
| Mar 2022 | - | $10.36 B(+8.4%) |
| Dec 2021 | $3.87 B(+7.0%) | $9.56 B(+8.0%) |
| Sept 2021 | - | $8.85 B(+4.7%) |
| June 2021 | - | $8.46 B(-1.0%) |
| Mar 2021 | - | $8.54 B(+5.0%) |
| Dec 2020 | $3.62 B(+3.5%) | $8.13 B(+9.0%) |
| Sept 2020 | - | $7.46 B(+11.4%) |
| June 2020 | - | $6.69 B(+22.9%) |
| Mar 2020 | - | $5.45 B(+12.9%) |
| Dec 2019 | $3.50 B(+45.5%) | $4.82 B(+1.0%) |
| Sept 2019 | - | $4.78 B(+1.4%) |
| June 2019 | - | $4.71 B(+12.6%) |
| Mar 2019 | - | $4.18 B(+8.8%) |
| Dec 2018 | $2.40 B(+167.9%) | $3.84 B(+4.2%) |
| Sept 2018 | - | $3.69 B(+8.2%) |
| June 2018 | - | $3.41 B(+12.0%) |
| Mar 2018 | - | $3.04 B(+14.8%) |
| Dec 2017 | $897.05 M(-15.8%) | $2.65 B(+13.8%) |
| Sept 2017 | - | $2.33 B(+6.8%) |
| June 2017 | - | $2.18 B(+16.5%) |
| Mar 2017 | - | $1.87 B(+2.2%) |
| Dec 2016 | $1.07 B(-2.4%) | $1.83 B(+21.9%) |
| Sept 2016 | - | $1.50 B(+3.3%) |
| June 2016 | - | $1.45 B(+3.7%) |
| Mar 2016 | - | $1.40 B(-0.3%) |
| Dec 2015 | $1.09 B(+38.5%) | $1.41 B(+3.5%) |
| Sept 2015 | - | $1.36 B(+5.0%) |
| June 2015 | - | $1.29 B(-4.7%) |
| Mar 2015 | - | $1.36 B(-12.2%) |
| Dec 2014 | $788.17 M(+7.9%) | $1.55 B(-6.3%) |
| Sept 2014 | - | $1.65 B(+22.5%) |
| June 2014 | - | $1.35 B(-5.8%) |
| Mar 2014 | - | $1.43 B(-10.0%) |
| Dec 2013 | $730.47 M(-37.6%) | $1.59 B(-3.6%) |
| Sept 2013 | - | $1.65 B(-4.0%) |
| June 2013 | - | $1.72 B(+9.6%) |
| Mar 2013 | - | $1.57 B(-1.5%) |
| Dec 2012 | $1.17 B(+34.0%) | $1.59 B(-2.7%) |
| Sept 2012 | - | $1.63 B(+2.6%) |
| June 2012 | - | $1.59 B(+10.9%) |
| Mar 2012 | - | $1.44 B(+7.9%) |
| Dec 2011 | $873.03 M(+30.6%) | $1.33 B(+6.9%) |
| Sept 2011 | - | $1.25 B(+50.6%) |
| June 2011 | - | $827.12 M(-5.3%) |
| Mar 2011 | - | $872.97 M(-17.4%) |
| Dec 2010 | $668.41 M(+3.1%) | $1.06 B(-13.8%) |
| Sept 2010 | - | $1.23 B(+22.1%) |
| June 2010 | - | $1.00 B(-10.8%) |
| Mar 2010 | - | $1.13 B(-13.8%) |
| Dec 2009 | $648.46 M(+474.4%) | $1.31 B(+43.0%) |
| Sept 2009 | - | $914.07 M(+16.8%) |
| June 2009 | - | $782.76 M(-13.2%) |
| Mar 2009 | - | $902.17 M(+4.0%) |
| Dec 2008 | $112.90 M(+7.9%) | $867.58 M(-9.0%) |
| Sept 2008 | - | $953.02 M(+11.1%) |
| June 2008 | - | $857.63 M(+9.4%) |
| Mar 2008 | - | $783.94 M(+57.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $104.63 M(-30.3%) | $496.85 M(-8.5%) |
| Sept 2007 | - | $543.28 M(-14.8%) |
| June 2007 | - | $637.66 M(-9.7%) |
| Mar 2007 | - | $706.54 M(-8.4%) |
| Dec 2006 | $150.17 M(-8.4%) | $771.41 M(+3.9%) |
| Sept 2006 | - | $742.70 M(+64.1%) |
| June 2006 | - | $452.59 M(+22.3%) |
| Mar 2006 | - | $370.05 M(-3.9%) |
| Dec 2005 | $163.94 M(+13.2%) | $385.06 M(-9.3%) |
| Sept 2005 | - | $424.33 M(-8.8%) |
| June 2005 | - | $465.31 M(+32.9%) |
| Mar 2005 | - | $350.03 M(-12.6%) |
| Dec 2004 | $144.81 M(+10.9%) | $400.64 M(-7.4%) |
| Sept 2004 | - | $432.83 M(-8.7%) |
| June 2004 | - | $474.21 M(-11.1%) |
| Mar 2004 | - | $533.44 M(-10.2%) |
| Dec 2003 | $130.60 M(-17.9%) | $593.81 M(-2.7%) |
| Sept 2003 | - | $610.27 M(-6.0%) |
| June 2003 | - | $649.24 M(-7.0%) |
| Mar 2003 | - | $697.98 M(+6.3%) |
| Dec 2002 | $159.15 M(+6.8%) | $656.57 M(-2.5%) |
| Sept 2002 | - | $673.65 M(-4.8%) |
| June 2002 | - | $707.61 M(-2.2%) |
| Mar 2002 | - | $723.78 M(-6.7%) |
| Dec 2001 | $149.04 M(-66.0%) | $776.09 M(+81.2%) |
| Sept 2001 | - | $428.42 M(+29.6%) |
| June 2001 | - | $330.47 M(-0.8%) |
| Mar 2001 | - | $333.28 M(-33.8%) |
| Dec 2000 | $437.85 M(+1075.5%) | $503.29 M(-30.3%) |
| Sept 2000 | - | $722.18 M(+87.3%) |
| June 2000 | - | $385.52 M(+9.0%) |
| Mar 2000 | - | $353.75 M(+81.2%) |
| Dec 1999 | $37.25 M(+111.6%) | $195.20 M(+0.6%) |
| Sept 1999 | - | $194.10 M(-8.1%) |
| June 1999 | - | $211.30 M(-6.8%) |
| Mar 1999 | - | $226.70 M(-8.8%) |
| Dec 1998 | $17.60 M(+25.7%) | $248.70 M(-4.7%) |
| Sept 1998 | - | $260.90 M(+1.2%) |
| June 1998 | - | $257.90 M(-3.6%) |
| Mar 1998 | - | $267.50 M(-5.0%) |
| Dec 1997 | $14.00 M(+23.9%) | $281.60 M(-1.4%) |
| Sept 1997 | - | $285.50 M(-0.8%) |
| June 1997 | - | $287.80 M(+4.0%) |
| Mar 1997 | - | $276.80 M(+109.4%) |
| Dec 1996 | $11.30 M(+1.8%) | $132.20 M(-0.2%) |
| Sept 1996 | - | $132.40 M(+112.9%) |
| June 1996 | - | $62.20 M(-20.9%) |
| Mar 1996 | - | $78.60 M(-10.6%) |
| Dec 1995 | $11.10 M(+19.4%) | $87.90 M(+0.2%) |
| Sept 1995 | - | $87.70 M(-7.9%) |
| June 1995 | - | $95.20 M(-5.4%) |
| Mar 1995 | - | $100.60 M(-5.9%) |
| Dec 1994 | $9.30 M(+17.7%) | $106.90 M(+10.1%) |
| Sept 1994 | - | $97.10 M(-4.7%) |
| June 1994 | - | $101.90 M(-3.7%) |
| Mar 1994 | - | $105.80 M(+99.2%) |
| Dec 1993 | $7.90 M(+12.9%) | $53.10 M(+23.8%) |
| Sept 1993 | - | $42.90 M(-1.8%) |
| June 1993 | - | $43.70 M(+7.4%) |
| Mar 1993 | - | $40.70 M(-7.5%) |
| Dec 1992 | $7.00 M(+29.6%) | $44.00 M(-6.0%) |
| Sept 1992 | - | $46.80 M(-2.7%) |
| June 1992 | - | $48.10 M(-2.2%) |
| Mar 1992 | - | $49.20 M(-4.8%) |
| Dec 1991 | $5.40 M(+17.4%) | $51.70 M(+88.7%) |
| Sept 1991 | - | $27.40 M(+996.0%) |
| June 1991 | - | $2.50 M(-45.7%) |
| Dec 1990 | $4.60 M | $4.60 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total current assets?
- What is the all time high annual current assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual current assets year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total current assets?
- What is the all time high quarterly current assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly current assets year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total current assets?
The current annual current assets of VRTX is $14.14 B
What is the all time high annual current assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total current assets is $14.14 B
What is Vertex Pharmaceuticals Incorporated annual current assets year-on-year change?
Over the past year, VRTX annual total current assets has changed by +$909.40 M (+6.87%)
What is Vertex Pharmaceuticals Incorporated quarterly total current assets?
The current quarterly current assets of VRTX is $9.80 B
What is the all time high quarterly current assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total current assets is $14.70 B
What is Vertex Pharmaceuticals Incorporated quarterly current assets year-on-year change?
Over the past year, VRTX quarterly total current assets has changed by -$4.89 B (-33.29%)